Masters Capital Management LLC Bristol Myers Squibb CO Transaction History

Masters Capital Management LLC

  • $2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $26.8 Million - $31.3 Million
-500,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $12.6 Million - $14.8 Million
213,720 Added 74.65%
500,000 $29.6 Million
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $693,271 - $864,085
-13,720 Reduced 4.57%
286,280 $15.8 Million
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $16.6 Million - $19.1 Million
300,000
300,000 $19.1 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Masters Capital Management LLC Portfolio

Follow Masters Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Masters Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Masters Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email